Genitourinary Cancer News

Most patients with cancer diagnosed with myocarditis after receiving immune checkpoint inhibitors showed evidence of liver dysfunction and muscle degradation, results of an observational cohort study in JACC CardioOncology showed.

Most oncology practices deployed immunotherapies as part of their clinical care strategy within 2 years of FDA approval for cancer indications, results of a study in JAMA Oncology showed.

A restrictive opioid prescription protocol of 3 days or less after hospital discharge appeared feasible among a cohort of patients who underwent surgery at a large cancer center, according to study results published in JAMA Oncology.

Black men have the highest rates of prostate cancer incidence and related mortality compared with all other racial and ethnic groups among U.S.-based men, results of an analysis published in European Urology showed.

The FDA has approved a gene therapy treatment for adult patients with high-risk bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer with carcinoma in situ with or without papillary tumors, according to a press release.

Genomic testing continues to provide oncologists with a wealth of meaningful, treatment-guiding information for a growing number of cancers.

Higher allostatic load, a measure of lifelong stress, correlated with increased risk for cancer mortality, especially among younger populations, according to study results published in SSM Population Health.

Many Americans lack awareness of the association between alcohol consumption and increased cancer risk, according to study results published in Cancer Epidemiology, Biomarkers and Prevention.

Roche voluntarily withdrew atezolizumab’s indication in the United States for the treatment of adults with locally advanced or metastatic urothelial carcinoma.

A dramatic rise in global incidence of early-onset cancers over the past 30 years may be related in part to increased exposure to risk factors at a young age, according to study results published in Nature Reviews Clinical Oncology,